Skip to content

PTSD — Comparative psychotherapy evidence

TL;DR — Trauma-focused CBT variants and EMDR have the strongest adult evidence, but rankings are much more certain against waitlist than against active treatments (Mavranezouli 2020, PMID 32063234) (Lewis 2020, PMID 32284821). In the adult network meta-analysis, evidence was moderate-to-low quality; EMDR and TF-CBT maintained benefit at 1–4 months, while longer follow-up was sparse (Mavranezouli 2020, PMID 32063234). Exposure’s advantage was negligible versus other trauma-focused treatments or medication in a separate meta-analysis (McLean 2022, PMID 34954460). Delivered benefit must combine symptom change, remission, function, harms and probability of completion.

Why rankings mislead

A high probability of being ‘best’ can coexist with wide intervals, sparse direct evidence and clinically trivial differences. Network assumptions require transitivity across trauma type, severity, setting and comparator.

Comparator gradient

Effects are largest versus waitlist, smaller versus attention/non-trauma-focused therapy and smallest versus another bona fide trauma-focused treatment (McLean 2022, PMID 34954460).

Outcome choice

End-of-treatment symptom score, diagnostic remission, response threshold, functioning and follow-up durability are not interchangeable. Missing data assumptions can reverse ordering when dropout differs (Carpenter 2018, PMID 29451967), and the difference is not hypothetical: in the largest randomized CPT-versus-PE trial (n=916 veterans) dropout was 52.31% in PE against 45.77% in CPT (Harper 2026, PMID 41926191). A 157-RCT network and pairwise meta-analysis of 11,565 patients found that all psychological interventions beat control, that interventions did not differ significantly from one another overall, but that TF-CBT outperformed non-trauma-focused interventions at short (g=0.17, 95% CI 0.03–0.31), mid (g=0.23, 95% CI 0.06–0.40) and long term (g=0.20, 95% CI 0.04–0.35) — while slightly more patients dropped out of TF-CBT than non-trauma-focused treatment (RR 1.36, 95% CI 1.08–1.70) (Hoppen 2023, PMID 37141033). Efficacy and acceptability point in opposite directions by a small margin, which is precisely why they must be reported together.

Trauma focus

Trauma-focused approaches have the clearest support, yet present-centred and other non-trauma-focused therapies may offer benefit and acceptability. ‘Not statistically superior’ is not proof of equivalence (Lewis 2020, PMID 32284821).

Complexity and comorbidity

Component NMA in complex traumatic events suggests people with comorbid problems can benefit, but pooled comorbidity is not a PTSD-only stratum and should be labelled (Coventry 2020, PMID 32813696). Depression outcomes remain depression outcomes.

Evidence gaps

Most networks have limited long-term, functional, adverse-event and patient-preference data. Therapist competence and implementation context are rarely randomised.

Quantitative anchors

Measure Estimate Population/method Source
Adult NMA 90 trials; n=6,560; 22 interventions Moderate-to-low certainty (Mavranezouli 2020, PMID 32063234)
Manualized review 114 RCTs; n=8,171 CBT-T and EMDR first-line (Lewis 2020, PMID 32284821)
Exposure review 65 articles; n=4,929 Comparator gradient (McLean 2022, PMID 34954460)
Broad review 64 trials Head-to-head evidence insufficient (Cusack 2016, PMID 26574151)
Complex-trauma component NMA psychological + pharmacological Comorbidity/complex-event scope (Coventry 2020, PMID 32813696)
Pediatric NMA 70 RCTs; n=5,528 Age-specific network (Hoppen 2025, PMID 39630422)
Adult NMA + pairwise 157 RCTs; n=11,565 Efficacy and acceptability together (Hoppen 2023, PMID 37141033)
TF-CBT vs non-TF, short term g=0.17 (95% CI 0.03–0.31) 190 comparisons (Hoppen 2023, PMID 37141033)
TF-CBT vs non-TF, long term g=0.20 (95% CI 0.04–0.35) >5 months post-treatment; 41 comparisons (Hoppen 2023, PMID 37141033)
TF-CBT vs non-TF dropout RR 1.36 (95% CI 1.08–1.70) 22 comparisons (Hoppen 2023, PMID 37141033)
EMDR vs other therapies (IPD) no significant difference (β=−0.24) Individual participant data (Wright 2024, PMID 38173121)

Evidence ledger

The ledger lists the live-retrieved records used to bound this page. Inclusion does not make every record equally probative; design, population and comparator remain decisive.

PMID Year Evidence contribution Scope caution
32063234 2020 Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Synthesis: preserve included-population and certainty limits
32284821 2020 Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
26574151 2016 Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
34954460 2022 Exposure therapy for PTSD: A meta-analysis. Synthesis: preserve included-population and certainty limits
32813696 2020 Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. Synthesis: preserve included-population and certainty limits
29451967 2018 Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Synthesis: preserve included-population and certainty limits
34473342 2022 Trauma-focused psychotherapies for post-traumatic stress disorder: A systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
37141033 2023 The efficacy and acceptability of psychological interventions for adult PTSD: A network and pairwise meta-analysis of randomized controlled trials. Synthesis: preserve included-population and certainty limits
37971855 2024 Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Synthesis: preserve included-population and certainty limits
32924926 2020 Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review. Synthesis: preserve included-population and certainty limits
40001042 2025 Mind-body intervention for post-traumatic stress disorder in adolescents: a systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
40476517 2025 Efficacy of psychosocial interventions on social functioning in individuals with childhood maltreatment experiences: a protocol for a systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
31313834 2020 Research Review: Psychological and psychosocial treatments for children and young people with post-traumatic stress disorder: a network meta-analysis. Synthesis: preserve included-population and certainty limits
34599050 2021 Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: a systematic review and network meta-analysis. Synthesis: preserve included-population and certainty limits
32353011 2020 Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults. PTSD-specific record; inspect design and population
31654414 2020 Cost-effectiveness of psychological interventions for children and young people with post-traumatic stress disorder. PTSD-specific record; inspect design and population
20546985 2010 A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Synthesis: preserve included-population and certainty limits
35278229 2022 Less dropout from prolonged exposure sessions prescribed at least twice weekly: A meta-analysis and systematic review of randomized controlled trials. Synthesis: preserve included-population and certainty limits
20614457 2010 Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). PTSD-specific record; inspect design and population
24382682 2014 Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. PTSD-specific record; inspect design and population
34477098 2021 Comparing treatments for post-traumatic stress disorder - a systematic review. Synthesis: preserve included-population and certainty limits
36628572 2023 Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled trials. Synthesis: preserve included-population and certainty limits
35413848 2022 The efficacy and acceptability of exposure therapy for the treatment of post-traumatic stress disorder in children and adolescents: a systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
31690461 2019 Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Synthesis: preserve included-population and certainty limits
39630422 2025 Psychological Interventions for Pediatric Posttraumatic Stress Disorder: A Systematic Review and Network Meta-Analysis. Synthesis: preserve included-population and certainty limits
41926191 2026 Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trial. PTSD-specific record; inspect design and population
38590124 2024 Cognitive-behavioural conjoint therapy versus prolonged exposure for PTSD in military service members and veterans: results and lessons from a randomized controlled trial. PTSD-specific record; inspect design and population
23842024 2013 Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. Synthesis: preserve included-population and certainty limits
38173121 2024 EMDR v. other psychological therapies for PTSD: a systematic review and individual participant data meta-analysis. Synthesis: preserve included-population and certainty limits

Interpretation guardrails

  • Trauma exposure, post-traumatic symptoms, acute stress disorder, DSM-5 PTSD, ICD-11 PTSD and ICD-11 complex PTSD are not interchangeable populations.
  • A mixed-anxiety or transdiagnostic estimate is labelled as such; only a source’s PTSD stratum can be treated as a PTSD effect.
  • Comorbid depression is measured separately and cross-linked to the depression condition; it is not absorbed into PTSD.
  • Waitlist, treatment-as-usual, attention control and active treatment answer different causal questions.
  • Registration, statistical significance and diagnostic loss do not respectively prove completion, clinical importance or functional recovery.
  • This page synthesizes research and does not provide individual medical advice.

Minimum extraction frame for studies on this topic

Field What must be retained Why it changes interpretation
Diagnostic system DSM version, ICD version, full/subthreshold Case mix is not interchangeable
Diagnostic method Structured interview, clinician judgment, self-report cutoff Screening is not diagnosis
Index trauma Type, timing, repetition, direct/indirect/occupational Conditional risk and phenotype differ
Population Civilian, veteran, refugee, child/adolescent, mixed Transportability is empirical
Baseline severity Mean, SD, range and exclusion threshold Ceiling and floor effects alter change
CPTSD status ITQ/ICD-11 definition and DSO score Complexity cannot be inferred from trauma count
Comorbidity Depression, GAD, SUD, pain, TBI measured separately Shared symptoms can distort effects
Comparator Waitlist, usual care, attention, active treatment The estimand changes with comparator
Treatment dose Sessions offered/attended, duration, homework Assignment is not exposure
Outcome Symptoms, diagnosis, response, function, sleep Outcomes are not interchangeable
Time point End point and prespecified follow-up windows Acute benefit may not persist
Missing data Denominator, reasons, imputation and estimand Attrition can bias rank and magnitude
Adverse events Definitions, ascertainment and arm-level counts Absence of reporting is not absence of harm
Therapist/context Training, fidelity, allegiance, setting Delivery is part of the intervention
Funding/conflicts Sponsor role and analytic independence Especially material for proprietary packages

Claims this page does not make

  • It does not infer PTSD from trauma exposure alone.
  • It does not treat a self-report cutoff as equivalent to a structured diagnosis.
  • It does not convert a pooled anxiety-disorder effect into a PTSD effect.
  • It does not convert a depression outcome in a comorbid sample into a PTSD outcome.
  • It does not infer superiority from a statistically significant within-group change.
  • It does not infer equivalence from a non-significant between-group test.
  • It does not infer effectiveness from trial registration or mechanistic plausibility.
  • It does not assume military, civilian, refugee and pediatric estimates transport unchanged.
  • It does not average conflicting estimates that use different definitions.
  • It does not treat lack of adverse-event reporting as evidence of safety.

Evidence-updating triggers

Trigger Required response
New diagnostic revision Recalculate which populations prior estimates represent
New head-to-head RCT Compare against active treatment, not only waitlist
New individual-participant synthesis Revisit effect modifiers and transportability
Registry status change Verify results and linked publication before changing conclusions
Guideline update Separate evidence review from panel recommendation
Regulatory decision Record decision date and source; do not infer from efficacy papers
Safety signal Re-extract denominator, ascertainment and exposure time by arm
Contradictory replication Display estimates side by side; do not average definitions

Evidence updates should preserve the prior estimate and explain why the new study changes—or does not change—the inference.

Open questions

  • Can an IPD network meta-analysis estimate retention-adjusted, patient-centred treatment effects? (Mavranezouli 2020, PMID 32063234) (Harper 2026, PMID 41926191)
  • Which apparent effect modifiers survive within-trial interaction testing? (McLean 2022, PMID 34954460)
  • How stable are rankings when high-risk-of-bias and waitlist-controlled studies are removed? (Mavranezouli 2020, PMID 32063234)

References

  1. Mavranezouli I, et al. Psychological treatments for post-traumatic stress disorder in adults: a network meta-analysis. Psychol Med. 2020;50(4):542-555. PMID 32063234
  2. Lewis C, et al. Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis. Eur J Psychotraumatol. 2020;11(1):1729633. PMID 32284821
  3. Cusack K, et al. Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2016;43:128-41. PMID 26574151
  4. McLean CP, et al. Exposure therapy for PTSD: A meta-analysis. Clin Psychol Rev. 2022;91:102115. PMID 34954460
  5. Coventry PA, et al. Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis. PLoS Med. 2020;17(8):e1003262. PMID 32813696
  6. Carpenter JK, et al. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35(6):502-514. PMID 29451967
  7. Jericho B, et al. Trauma-focused psychotherapies for post-traumatic stress disorder: A systematic review and network meta-analysis. Acta Psychiatr Scand. 2022;145(2):132-155. PMID 34473342
  8. Hoppen TH, et al. The efficacy and acceptability of psychological interventions for adult PTSD: A network and pairwise meta-analysis of randomized controlled trials. J Consult Clin Psychol. 2023;91(8):445-461. PMID 37141033
  9. Hien DA, et al. Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Psychol Bull. 2024;150(3):319-353. PMID 37971855
  10. Melton H, et al. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review. Health Technol Assess. 2020;24(43):1-312. PMID 32924926
  11. Bianjiang Z, et al. Mind-body intervention for post-traumatic stress disorder in adolescents: a systematic review and network meta-analysis. BMC Psychiatry. 2025;25(1):178. PMID 40001042
  12. Fares-Otero NE, et al. Efficacy of psychosocial interventions on social functioning in individuals with childhood maltreatment experiences: a protocol for a systematic review and network meta-analysis. Eur J Psychotraumatol. 2025;16(1):2508548. PMID 40476517
  13. Mavranezouli I, et al. Research Review: Psychological and psychosocial treatments for children and young people with post-traumatic stress disorder: a network meta-analysis. J Child Psychol Psychiatry. 2020;61(1):18-29. PMID 31313834
  14. Xiang Y, et al. Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: a systematic review and network meta-analysis. Evid Based Ment Health. 2021;24(4):153-160. PMID 34599050
  15. Mavranezouli I, et al. Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults. PLoS One. 2020;15(4):e0232245. PMID 32353011
  16. Mavranezouli I, et al. Cost-effectiveness of psychological interventions for children and young people with post-traumatic stress disorder. J Child Psychol Psychiatry. 2020;61(6):699-710. PMID 31654414
  17. Powers MB, et al. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev. 2010;30(6):635-41. PMID 20546985
  18. Levinson DB, et al. Less dropout from prolonged exposure sessions prescribed at least twice weekly: A meta-analysis and systematic review of randomized controlled trials. J Trauma Stress. 2022;35(4):1047-1059. PMID 35278229
  19. Hetrick SE, et al. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2010;2010(7):CD007316. PMID 20614457
  20. Jayawickreme N, et al. Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. Depress Anxiety. 2014;31(5):412-9. PMID 24382682
  21. Storm MP, et al. Comparing treatments for post-traumatic stress disorder - a systematic review. Dan Med J. 2021;68(9):A09200643. PMID 34477098
  22. Yunitri N, et al. Comparative effectiveness of psychotherapies in adults with posttraumatic stress disorder: a network meta-analysis of randomised controlled trials. Psychol Med. 2023;53(13):6376-6388. PMID 36628572
  23. Huang T, et al. The efficacy and acceptability of exposure therapy for the treatment of post-traumatic stress disorder in children and adolescents: a systematic review and meta-analysis. BMC Psychiatry. 2022;22(1):259. PMID 35413848
  24. Sonis J, et al. Medication versus trauma-focused psychotherapy for adults with posttraumatic stress disorder: A systematic review and meta-analysis. Psychiatry Res. 2019;282:112637. PMID 31690461
  25. Hoppen TH, et al. Psychological Interventions for Pediatric Posttraumatic Stress Disorder: A Systematic Review and Network Meta-Analysis. JAMA Psychiatry. 2025;82(2):130-141. PMID 39630422
  26. Harper KL, et al. Comparing dropout from cognitive processing therapy versus prolonged exposure: Results from a randomized clinical trial. J Consult Clin Psychol. 2026;94(3):140-150. PMID 41926191
  27. Monson CM, et al. Cognitive-behavioural conjoint therapy versus prolonged exposure for PTSD in military service members and veterans: results and lessons from a randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2330305. PMID 38590124
  28. Watts BV, et al. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74(6):e541-50. PMID 23842024
  29. Wright SL, et al. EMDR v. other psychological therapies for PTSD: a systematic review and individual participant data meta-analysis. Psychol Med. 2024;54(8):1580-1588. PMID 38173121